source
- FDA approves Lilly's once-weekly basal insulin Onswik for adults with type 2 diabetesThe U.S. Food and Drug Administration has granted approval to Eli Lilly’s Onswik, a basal insulin designed for once-weekly injection in adults with type 2 diabetes. The new formulation offers patie…
- Merck's Welireg receives FDA nod for expanded use with Lenvima in kidney cancerMerck announced that its drug Welireg has received FDA approval for use together with Eisai's Lenvima in patients with advanced renal cell carcinoma. The clearance broadens the indication, allowin…